Description

AOD-9604 10MG

We provide AOD-9604 as a 10MG research peptide with a stated 99.1% purity. Furthermore, this modified peptide represents a synthetic analogue of the C-terminal lipolytic domain of human growth hormone. Consequently, researchers have examined its relationship with adipose-tissue biology, lipid metabolism, lipolysis, and related metabolic pathways.

AOD-9604 Product Overview

We provide the material for research involving adipocyte biology, lipid metabolism, lipolytic activity, and growth-factor research. Moreover, experimental studies have reported that the peptide can stimulate lipolysis and inhibit lipogenesis in adipose-tissue models. Therefore, researchers can examine its activity within controlled experimental systems.

Explore additional research materials through our Online Store.

AOD-9604 Product Identification

We identify AOD-9604 as a modified 16-amino-acid peptide. PubChem lists the sequence as YLRIVQCRSVEGSCGF and reports a molecular weight of 1,815.1 g/mol. Accordingly, the sequence, molecular weight, quantity, purity designation, and vial format provide clear reference points for laboratory documentation.

Product Category

We classify the material within our research peptide collection for metabolic and adipose-tissue investigation. Furthermore, researchers have examined its relationship with beta-adrenergic signaling, lipid oxidation, and lipolytic responses. Experimental work in obese mice found increased beta-3 adrenergic receptor RNA expression alongside changes in body weight and lipolysis. Consequently, the material remains relevant to studies examining adipocyte signaling and lipid metabolism.

Scientific Characteristics

AOD-9604 contains a defined 16-residue sequence with a disulfide connection between its cysteine residues. Moreover, its structure differs from native human growth hormone while retaining characteristics associated with the hormone’s C-terminal functional region. Researchers have also examined how structural modification influences receptor interactions and biological activity.

Importantly, experimental work found that the peptide did not compete for the human growth hormone receptor in one cell-based model and did not induce cell proliferation through that receptor. Therefore, researchers can distinguish its investigated activity from classical growth-hormone receptor signaling.

Research Applications

We position AOD-9604 for research involving lipolysis, lipogenesis, adipocyte biology, lipid oxidation, beta-adrenergic pathways, and metabolic signaling. Additionally, studies in adipose tissues have reported increased lipolytic activity following exposure to the peptide. Likewise, experimental research has examined changes in fat oxidation and circulating glycerol as indicators associated with altered lipid metabolism.

Furthermore, researchers have investigated beta-3 adrenergic receptor expression as part of its broader metabolic profile. Nevertheless, experimental results depend on the biological model, exposure conditions, and measured endpoint. Accordingly, researchers should evaluate individual findings within their specific experimental context.

Product Configuration

We provide AOD-9604 in a 10MG vial carrying a stated 99.1% purity designation. Moreover, the defined quantity, peptide identity, purity specification, and physical presentation establish straightforward reference points for laboratory inventory.

Additionally, the vial configuration distinguishes this presentation from other research peptide formats. Consequently, researchers can organize the material according to its product name, quantity, purity, molecular identity, and research classification.

Product Features

The primary features include a 10MG quantity, 99.1% stated purity, defined peptide sequence, and research-use presentation. Furthermore, the product label communicates Not For Human Use | Research Use Only.

Moreover, AOD-9604 has a research profile involving adipose-tissue metabolism and lipolytic mechanisms. Researchers have investigated its effects in rodent adipose tissue and other experimental models, while structural studies have examined its relationship with the C-terminal region of human growth hormone.

Product Specifications

The molecular sequence, formula, and molecular weight correspond with the chemical identity documented by PubChem.

Intended Research Context

We identify the material as Research Use Only and Not For Human Use. Accordingly, our documentation focuses on laboratory investigation rather than therapeutic or consumer applications.

In particular, researchers can examine the material within experimental systems involving adipose-tissue biology, lipid metabolism, lipolytic signaling, and peptide structure. Furthermore, published studies provide experimental evidence concerning its metabolic activity, while additional research continues to clarify its molecular mechanisms.

Packaging Information

We present the product in a clearly labeled 10MG vial featuring our AvigenLab product presentation. The packaging identifies the compound, displays the 10MG quantity, and communicates the stated 99.1% Purity designation.

Additionally, the label communicates Not For Human Use | Research Use Only. Therefore, the packaging provides straightforward identification while supporting consistent laboratory inventory and catalog organization.

Regulatory Information

We classify the product as Research Use Only and maintain the Not For Human Use designation throughout our product documentation. Accordingly, scientific publications concerning the peptide do not constitute regulatory approval for this specific AvigenLab presentation.

Moreover, experimental findings do not automatically establish clinical outcomes. Consequently, we document the material according to its molecular identity, research applications, product specifications, and published scientific evidence without presenting laboratory observations as established therapeutic claims.

Storage and Handling

We recommend following the storage and handling conditions specified in the applicable AvigenLab product documentation. Because peptide stability can depend on formulation, packaging, environmental exposure, and other product-specific variables, we avoid assigning unsupported storage parameters.

Furthermore, researchers should maintain appropriate laboratory handling practices and follow the product-specific documentation associated with the material. Consequently, this approach supports consistent laboratory management without introducing assumptions about conditions that may vary between formulations.

Market Availability

Our 10MG presentation provides a defined research peptide configuration within our product collection. The product quantity, stated purity, molecular identity, vial format, and Research Use Only designation create clear reference points for laboratory inventory.

Moreover, the compound has an established research history spanning adipose-tissue biology, lipid metabolism, lipolysis, and growth-hormone fragment research. Likewise, continued investigation into its metabolic pathways keeps the material relevant to experimental research.

Product Reference

Our AOD-9604 10MG presentation provides a defined synthetic peptide with a stated 99.1% purity designation. We document the material according to its molecular sequence, structural characteristics, vial configuration, research applications, and Research Use Only classification.

Consequently, the product provides researchers with a clearly identified material for investigating lipolytic activity, lipid metabolism, adipose-tissue signaling, and related metabolic mechanisms. Furthermore, ongoing research continues to examine how this modified growth-hormone fragment produces biological effects that differ from classical growth-hormone receptor signaling.